CHAMPion

Sign up to be a CHAMPion to get involved with your community and advocacy

We are the Coalition For
Headache And Migraine Patients

Education

Improving patient journeys and ending stigma

Community

Connecting and strengthening patient advocates and people with headache diseases

Advocacy

Ensuring everyone has access to effective treatments for headache diseases

RetreatMigraine has concluded for 2019. Please check back for announcements about future events. This conference for 250+ people from across America living with migraine disease will be a community-bonding, treatment-learning and advocate-making experience.

Group
CGRP Financial Guide Thumbnails

CGRP Financial Assistance Guides

CHAMP has created Financial Assistance Guides to help patients understand the many support programs provided by the manufacturers of the new CGRP inhibitor medicines for the prevention of migraine. There are currently three CGRP medications on the market: Aimovig™, Emgality™ and AJOVY™.

Latest News

Three arms with the RetreatMigraine tattooed on them.

RetreatMigraine: A Lasting Impression

This past weekend the members of CHAMP hosted RetreatMigraine, a 3-day education conference for people living with migraine disease. More than 200 people came to San Antonio, TX to connect, experience and heal with those who understand without saying a word. Throughout the weekend, attendees learned more about their disease, various ways in which to…

Read More...
Headache On The Hill

CHAMPions, We Need Your Help to Advocate for Those Disabled by Headache Diseases

Our community made great strides at this year’s Headache on the Hill, led by our partner, the Alliance for Headache Advocacy Disorders (AHDA). We met with hundreds of offices to ask our members of Congress to support requests for specific report language. The requests would direct the Social Security Administration (SSA) to include headache diseases…

Read More...
Respect Migrane Disease Cover CGRP Medicines

CHAMP Calls for CGRP Coverage in the UK

The UK’s National Institute for Health and Care Excellence (NICE) recently released draft guidance indicating that they will not approve Aimovig (erenumab) for coverage through the country’s National Health Service. While those prescribed Aimovig, a CGRP inhibitor produced by Novartis/Amgen, may pay out-of-pocket to receive the treatment, the cost of the medicine will keep many…

Read More...

Coalition For Headache And Migraine Patients

CHAMP helps people with headache diseases by providing information, resources, events, community  and advocacy.

CHAMP brings together organizations and leaders in this disease area to enhance communication, coordination and collaboration.

Members of CHAMP standing on a green lawn with a banner with the logo on it.

Clinical Trials

The search for better treatments requires people willing to participate in clinical trials. Use our tool to find trials in your area that you may be eligible for.

Accessing Treatments and Understanding Insurance

Click on the images below to view migraine content from CHAMP member organization, the Patient Advocate Foundation.